Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Non-cash Items: 2018-2022

Historic Non-cash Items for ProPhase Labs (PRPH) over the last 5 years, with Sep 2022 value amounting to $32.9 million.

  • ProPhase Labs' Non-cash Items rose 161.96% to $32.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $32.9 million, marking a year-over-year increase of 161.96%. This contributed to the annual value of $20.8 million for FY2021, which is 21.26% down from last year.
  • Per ProPhase Labs' latest filing, its Non-cash Items stood at $32.9 million for Q3 2022, which was down 28.73% from $46.2 million recorded in Q2 2022.
  • In the past 5 years, ProPhase Labs' Non-cash Items ranged from a high of $46.2 million in Q2 2022 and a low of $420,000 during Q3 2019.
  • Moreover, its 3-year median value for Non-cash Items was $20.3 million (2021), whereas its average is $20.3 million.
  • In the last 5 years, ProPhase Labs' Non-cash Items plummeted by 85.06% in 2019 and then surged by 2,336.96% in 2020.
  • Quarterly analysis of 5 years shows ProPhase Labs' Non-cash Items stood at $3.2 million in 2018, then crashed by 66.46% to $1.1 million in 2019, then soared by 2,336.96% to $26.4 million in 2020, then dropped by 21.26% to $20.8 million in 2021, then skyrocketed by 161.96% to $32.9 million in 2022.
  • Its Non-cash Items was $32.9 million in Q3 2022, compared to $46.2 million in Q2 2022 and $20.8 million in Q1 2022.